LQDA Liquidia Corp
company
SEC Filings & Insider Trading Activity 2026

CIK: 1819576
Health Care
Pharmaceutical Preparations 23 filings
Russell 2000

Latest Liquidia Corp (LQDA) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 5, 2026, a 10-Q quarterly report filed on November 3, 2025, an 8-K current report filed on March 5, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Liquidia Corp (LQDA) (SEC CIK 1819576), with AI-powered section-by-section summaries updated daily.

10-Q: 15
10-K: 6
8-K: 2

Latest 2026 SEC Filing Dates

10-K Annual Report
Mar 5, 2026
10-Q Quarterly Report
Nov 3, 2025
8-K Current Report
Mar 5, 2026

AI 10-K Annual Report Analysis
Latest 10-K (2025-12-31)

Business Overview

  • Core business model: Development and commercialization of inhaled treprostinil therapies for PAH and PH-ILD leveraging proprietary PRINT particle engineering technology
  • New product launch: FDA approved and commercialized YUTREPIA inhalation powder in May-June 2025, designed for higher dosing and improved lung delivery
+3 more insights

Risk Factors

  • Cybersecurity risk with potential material disruption of product development programs and financial losses due to IT system failures or data breaches
  • Board Audit Committee oversight of cybersecurity risks with regular management reporting on security controls and incident response effectiveness
+3 more insights

Management Discussion & Analysis

  • Revenue $158.3M in 2025 vs $14.0M in 2024; product sales $148.3M from YUTREPIA launches, service revenue down 28% to $10.0M
  • Operating loss improved to $(51.4)M in 2025 vs $(121.3)M in 2024; SG&A rose 93% to $157.2M, R&D decreased 18% to $39.3M
+3 more insights

AI 10-Q Quarterly Report Analysis
Latest 10-Q (2025-09-30)

Risk Factors

  • New legal risk: United Therapeutics lawsuits seeking injunction to remove YUTREPIA from PAH/PH-ILD markets, risking loss of FDA approval or sales suspension
  • Most material update: Accumulated deficit $640.9M as of Sep 30, 2025, net losses $83.5M (9 months 2025) versus $128.3M (2024) and $78.5M (2023), ongoing loss uncertainty
Read full Q3 2025 10-Q analysis →

AI 8-K Current Report Analysis
Recent 8-K Filings

Filed Mar 5, 2026
8-K
Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q4 or full-year 2025 earnings results disclosed via press release exhibit, signed March 5, 2026
  • Full financial details in the accompanying exhibit — no key figures included in the 8-K body text

Annual Reports Archive
10-K

AI-powered analysis of Liquidia Corp (LQDA) 10-K annual reports filed with SEC EDGAR.

Quarterly Reports Archive
10-Q

AI-powered analysis of Liquidia Corp (LQDA) 10-Q quarterly reports filed with SEC EDGAR.

Recent 8-K Filings
Current Reports

AI-powered analysis of Liquidia Corp (LQDA) 8-K current reports disclosing material events.

Financial Summary
XBRL

FY2022FY2023FY2024FY2025
Profitability
Revenue$15.9M$17.5M$14.0M$158.3M
Operating Income-$38.8M-$73.4M-$121.3M-$51.4M
Net Income-$41.0M-$78.5M-$130.4M-$68.9M
Op. Margin-243.3%-419.6%-866.6%-32.5%
Net Margin-257.4%-448.9%-931.7%-43.5%
Balance Sheet
Total Assets$129.2M$118.3M$230.3M$327.9M
Equity$90.4M$47.3M$77.3M$44.7M
ROE-45.4%-166.0%-168.7%-154.0%

Source: XBRL financial data from Liquidia Corp (LQDA) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.

Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4

FormFiling DatePeriodAnalysisSEC
8-K
Mar 5, 2026Analysis
10-K
Mar 5, 2026Dec 31, 2025Analysis
8-K
Jan 9, 2026
10-Q
Nov 3, 2025Sep 30, 2025Analysis
10-Q
Aug 12, 2025Jun 30, 2025
10-Q
May 8, 2025Mar 31, 2025
10-K
Mar 19, 2025Dec 31, 2024
10-Q
Nov 13, 2024Sep 30, 2024
10-Q
Aug 7, 2024Jun 30, 2024
10-Q
May 13, 2024Mar 31, 2024
10-K
Mar 13, 2024Dec 31, 2023
10-Q
Nov 7, 2023Sep 30, 2023
10-Q
Aug 10, 2023Jun 30, 2023
10-Q
May 8, 2023Mar 31, 2023
10-K
Mar 20, 2023Dec 31, 2022
10-Q
Nov 8, 2022Sep 30, 2022
10-Q
Aug 11, 2022Jun 30, 2022
10-Q
May 12, 2022Mar 31, 2022
10-K
Mar 17, 2022Dec 31, 2021
10-Q
Nov 3, 2021Sep 30, 2021
10-Q
Aug 10, 2021Jun 30, 2021
10-Q
May 13, 2021Mar 31, 2021
10-K
Mar 25, 2021Dec 31, 2020

Frequently Asked Questions

What are the latest LQDA SEC filings in 2026?

Liquidia Corp (LQDA) has filed a 10-K annual report on March 5, 2026, a 10-Q quarterly report on November 3, 2025, an 8-K current report on March 5, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did LQDA file its most recent 10-K annual report?

Liquidia Corp (LQDA) filed its most recent 10-K annual report on March 5, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view LQDA 10-Q quarterly reports?

Liquidia Corp (LQDA)'s most recent 10-Q quarterly report was filed on November 3, 2025. SignalX displays every LQDA 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has LQDA filed recently?

Liquidia Corp (LQDA)'s most recent 8-K was filed on March 5, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find LQDA insider trading activity (Form 4)?

SignalX aggregates every LQDA Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does LQDA file with the SEC?

Liquidia Corp (LQDA) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new LQDA filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Liquidia Corp (LQDA).

What is LQDA's SEC CIK number?

Liquidia Corp (LQDA)'s SEC CIK (Central Index Key) number is 1819576. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1819576 to look up all LQDA filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find LQDA return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Liquidia Corp (LQDA) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.

Stay on top of Liquidia Corp SEC filings

Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 23+ filings.